Nalaganje...
Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.
OBJECTIVE--To compare the efficacy and side effects of 400 mg, 800 mg, and 1200 mg zidovudine daily in patients with AIDS or advanced HIV infection. DESIGN--Randomised, double blind, parallel group multicentre study. SETTING--Hospital departments of infectious diseases and dermatology in Denmark, Sw...
Shranjeno v:
| Format: | Artigo |
|---|---|
| Jezik: | Inglês |
| Izdano: |
1992
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1880952/ https://ncbi.nlm.nih.gov/pubmed/1346505 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|